https://www.selleckchem.com/pr....oducts/tyloxapol.htm
027). Annual antidepressant medication spending had a larger, nonsignificant increase ($89 [95% CI -$20 to $197]; P = 0.109). Annual spending on medical care services had a smaller, nonsignificant decrease (-$54 [95% CI -$832 to $941]; P = 0.905). HRQoL had a nonsignificant increase (0.011 [95% CI -0.025 to 0.047]; P = 0.546). CONCLUSIONS The RAINBOW intervention's economic value will depend on how its 1-year improvements in obesity and depression translate into long-term reduced morbidity, delayed mortality, or averted costs. © 2020